SHARE
 
Carey E. Gleason, PhD close
Carey E. Gleason, PhD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Carey E. Gleason, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Carey E. Gleason, PhD completed her education at the California School of Professional Psychology.

Specialties

Clinics

Fitchburg Clinic
(608) 263-7740 | | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Education California School of Professional Psychology, Fresno, CA
Fellowship

Geropsychology Fellowship, Loius Stokes Cleveland Veterans Administrations Medical Center, Cleveland, OH; Neuropsychology Fellowship; University of Washington, Geriatric Research, Education and Clinical Center (GRECC), Tacoma, WA



Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Miller VM Naftolin F Asthana S Black DM Brinton EA Budoff MJ Cedars MI Dowling NM Gleason CE Hodis HN Jayachandran M Kantarci K Lobo RA Manson JE Pal L Santoro NF Taylor HS Harman SM The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause . 2019 Apr 1;
[PubMed ID: 30939537]
Bruno D Gleason CE Koscik RL Pomara N Zetterberg H Blennow K Johnson SC The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD. Int J Geriatr Psychiatry . 2019 Mar;34(3):415-419
[PubMed ID: 30430632]
Umucu E Wyman M Lee B Zuelsdorff M Benton SF Nystrom N Johnson SC Carlsson CM Asthana S Gleason CE Apathy in Preclinical Alzheimer's Disease: Psychometric Validation of the Apathy Evaluation Scale. Am J Alzheimers Dis Other Demen . 2019 Feb;34(1):16-22
[PubMed ID: 30103612]
Koscik RL Norton DL Allison SL Jonaitis EM Clark LR Mueller KD Hermann BP Engelman CD Gleason CE Sager MA Chappell RJ Johnson SC Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study. J Int Neuropsychol Soc . 2019 Feb;25(2):119-133
[PubMed ID: 30522545]
Koscik RL Jonaitis EM Clark LR Mueller KD Allison SL Gleason CE Chappell RJ Hermann BP Johnson SC Longitudinal Standards for Mid-life Cognitive Performance: Identifying Abnormal Within-Person Changes in the Wisconsin Registry for Alzheimer's Prevention. J Int Neuropsychol Soc . 2019 Jan;25(1):1-14
[PubMed ID: 30482257]
Morgan KN Derby CA Gleason CE Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause. Obstet Gynecol Clin North Am . 2018 Dec;45(4):751-763
[PubMed ID: 30401555]
Beeri MS Lin HM Sano M Ravona-Springer R Liu X Bendlin BB Gleason CE Guerrero-Berroa E Soleimani L Launer LJ Ehrenberg S Lache O Seligman YK Levy AP Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study. JAMA Netw Open . 2018 Nov 2;1(7):e184458
[PubMed ID: 30646354]
Christensen K Gleason CE Mares JA Dietary carotenoids and cognitive function among US adults, NHANES 2011-2014. Nutr Neurosci . 2018 Oct 16;:1-9
[PubMed ID: 30326796]
Gilmore-Bykovskyi AL Block LM Walljasper L Hill N Gleason C Shah MN Unstructured clinical documentation reflecting cognitive and behavioral dysfunction: toward an EHR-based phenotype for cognitive impairment. J Am Med Inform Assoc . 2018 Sep 1;25(9):1206-1212
[PubMed ID: 29947805]
Kantarci K Tosakulwong N Lesnick TG Zuk SM Lowe VJ Fields JA Gunter JL Senjem ML Settell ML Gleason CE Shuster LT Bailey KR Dowling NM Asthana S Jack CR Jr Rocca WA Miller VM Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology . 2018 Apr 17;90(16):e1404-e1412
[PubMed ID: 29661902]
Gleason CE Norton D Anderson ED Wahoske M Washington DT Umucu E Koscik RL Dowling NM Johnson SC Carlsson CM Asthana S Alzheimer’s Disease Neuroimaging Initiative. Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker. J Alzheimers Dis . 2018;61(1):79-89
[PubMed ID: 29125485]
Santoro N Allshouse A Neal-Perry G Pal L Lobo RA Naftolin F Black DM Brinton EA Budoff MJ Cedars MI Dowling NM Dunn M Gleason CE Hodis HN Isaac B Magnani M Manson JE Miller VM Taylor HS Wharton W Wolff E Zepeda V Harman SM Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause . 2017 Mar;24(3):238-246
[PubMed ID: 27779568]
Messina M Gleason C Evaluation of the potential antidepressant effects of soybean isoflavones. Menopause . 2016 Dec;23(12):1348-1360
[PubMed ID: 27552470]
Koscik RL Berman SE Clark LR Mueller KD Okonkwo OC Gleason CE Hermann BP Sager MA Johnson SC Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention. J Int Neuropsychol Soc . 2016 Nov;22(10):1016-1025
[PubMed ID: 27903330]
Kantarci K Tosakulwong N Lesnick TG Zuk SM Gunter JL Gleason CE Wharton W Dowling NM Vemuri P Senjem ML Shuster LT Bailey KR Rocca WA Jack CR Jr Asthana S Miller VM Effects of hormone therapy on brain structure: A randomized controlled trial. Neurology . 2016 Aug 30;87(9):887-96
[PubMed ID: 27473135]
Racine AM Koscik RL Berman SE Nicholas CR Clark LR Okonkwo OC Rowley HA Asthana S Bendlin BB Blennow K Zetterberg H Gleason CE Carlsson CM Johnson SC Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife. Brain . 2016 Aug;139(Pt 8):2261-74
[PubMed ID: 27324877]
Gleason CE Dowling NM Benton SF Kaseroff A Gunn W Edwards DF Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive Impairment. Am J Geriatr Psychiatry . 2016 Jul;24(7):537-46
[PubMed ID: 26809602]
Anderson ED Wahoske M Huber M Norton D Li Z Koscik RL Umucu E Johnson SC Jones J Asthana S Gleason CE Alzheimer's Disease Neuroimaging Initiative. Cognitive variability-A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (Amst) . 2016;4:47-55
[PubMed ID: 27489880]
Kantarci K Lowe VJ Lesnick TG Tosakulwong N Bailey KR Fields JA Shuster LT Zuk SM Senjem ML Mielke MM Gleason C Jack CR Rocca WA Miller VM Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis . 2016 May 7;53(2):547-56
[PubMed ID: 27163830]
Hoscheidt SM Starks EJ Oh JM Zetterberg H Blennow K Krause RA Gleason CE Puglielli L Atwood CS Carlsson CM Asthana S Johnson SC Bendlin BB Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults. J Alzheimers Dis . 2016 Apr 12;52(4):1373-83
[PubMed ID: 27079723]